AIP
FTXH icon

Ameritas Investment Partners’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Ameritas Investment Partners’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.03M Buy
30,065
+11,967
+66% +$409K 0.03% 590
2025
Q4 		$596K Buy
18,098
+866
+5% +$27K 0.02% 784
2025
Q3 		$491K Buy
17,232
+1,521
+10% +$41.4K 0.02% 827
2025
Q2 		$403K Buy
15,711
+391
+3% +$9.9K 0.01% 934
2025
Q1 		$421K Buy
15,320
+1,147
+8% +$31.8K 0.01% 895
2024
Q4 		$382K Buy
14,173
+1,633
+13% +$45.8K 0.01% 956
2024
Q3 		$362K Buy
12,540
+500
+4% +$14.3K 0.01% 975
2024
Q2 		$328K Buy
12,040
+840
+8% +$22.5K 0.01% 971
2024
Q1 		$314K Buy
11,200
+587
+6% +$16.2K 0.01% 1008
2023
Q4 		$282K Buy
10,613
+56
+0.5% +$1.41K 0.01% 1066
2023
Q3 		$270K Sell
10,557
-90
-0.8% -$2.38K 0.01% 1004
2023
Q2 		$279K Sell
10,647
-41
-0.4% -$1.08K 0.01% 954
2023
Q1 		$279K Buy
10,688
+58
+0.5% +$1.55K 0.01% 929
2022
Q4 		$292K Buy
10,630
+791
+8% +$21K 0.01% 939
2022
Q3 		$236K Buy
+9,839
New +$254K 0.01% 983

Other funds holding FTXH

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
MIM
Marshall Investment Management Littleton, Colorado $208M AUM 30.96% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
NP
Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
VCM
Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Ameritas Investment Partners's FTXH Position: Q1 2026 in Review

Ameritas Investment Partners increased its First Trust Nasdaq Pharmaceuticals ETF (FTXH) stake by 66% in Q1 2026, buying an estimated $409K and bringing the position to 30,065 shares worth $1.03M. The position accounts for 0.03% of the portfolio, ranked #590.

Ameritas Investment Partners first reported a position in FTXH in Q3 2022 and has held it in 15 quarters since. 32 funds tracked by Wall St. Rank hold FTXH as of Q1 2026.

  • Ameritas Investment Partners held 30,065 shares of First Trust Nasdaq Pharmaceuticals ETF worth $1.03M as of Q1 2026.
  • Ameritas Investment Partners bought 11,967 First Trust Nasdaq Pharmaceuticals ETF shares in Q1 2026, an estimated $409K.
  • First Trust Nasdaq Pharmaceuticals ETF made up 0.03% of Ameritas Investment Partners's portfolio in Q1 2026, its #590 holding.
  • Ameritas Investment Partners first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q3 2022 and has held it in 15 quarters since.
  • 32 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.